How could a pooled testing policy have performed in managing the early stages of the COVID-19 pandemic? Results from a simulation study
From MaRDI portal
Publication:6618511
DOI10.1002/SIM.10062zbMATH Open1545.62345MaRDI QIDQ6618511
Sofía S. Villar, David S. Robertson, Bethany Heath
Publication date: 14 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Could not fetch data.
Cites Work
- Informative Dorfman Screening
- On the Detection of Defective Members of Large Populations
- Informative Retesting
- Optimal diagnostic test allocation strategy during the COVID-19 pandemic and beyond
- Is group testing ready for prime-time in disease identification?
- Discussion on: ``Is group testing ready for prime-time in disease identification?
- Discussion of: ``Is group testing ready for prime-time in disease identification?
- Rejoinder to discussion on: ``Is group testing ready for prime-time in disease identification?
This page was built for publication: How could a pooled testing policy have performed in managing the early stages of the COVID-19 pandemic? Results from a simulation study
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6618511)
